
|Videos|January 8, 2021
Pharmaceutical CEO Leadership: Diversity in Pharma - Measuring Progress
In this segment, members of the Pharmaceutical CEO Leadership: Diversity in Pharma panel talk about how employees need to be consciously inclusive and why their actions should be measured not just by what they achieve but by how they go about it. Collecting data is beneficial, but it becomes even more meaningful when employees see how their input translates into action. Creating a strategic plan can offer clear goals to work toward.
Advertisement
Newsletter
Lead with insight with the Pharmaceutical Executive newsletter, featuring strategic analysis, leadership trends, and market intelligence for biopharma decision-makers.
Advertisement
Advertisement
Advertisement
Trending on PharmExec
1
FDA Appoints Tracy Beth Høeg as Acting Director of CDER
2
Mark Cuban Pushes for Generic Drug Fee Waivers, as Cost Plus Drugs Eyes US Manufacturing Expansion
3
Five Steps for Successful CGT Commercialization Through Health Systems Partnerships
4
FDA Approves Expanded Indication of Jaypirca for Adults with Relapsed or Refractory Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma
5





